146
Participants
Start Date
February 29, 2016
Primary Completion Date
October 31, 2020
Study Completion Date
August 31, 2021
Octreotide capsules
Columbia University Medical Center, New York
Allegheny Endocrinology Associates, Pittsburgh
Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela
Thomas Jefferson University, Philadelphia
Johns Hopkins University, Baltimore
Praxis für Endokrinologie und Diabetologie Dr M Droste, Oldenburg
Hospital General Universitario Gregorio Maranon, Madrid
Emory University, Atlanta
University of Alabama at Birmingham, Birmingham
The Ohio State University Wexner Medical Center, Columbus
Campus Del Hospital Universitario Virgen del Rocio, Seville
Hospital Universitario de la Ribera, Alzira
Università di Pisa Dipartimento di Medicina Clinica e Sperimentale, Pisa
Northwestern University, Chicago
John H. Stroger, Jr. Hospital of Cook County, Chicago
Washington University School of Medicine, St Louis
Hospices Civils de Lyon, Bron
Baylor College of Medicine, Houston
Houston Methodist Research Institute, Houston
University of Colorado Denver, Aurora
Keck Medical Center of University of Southern California, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Hôpital Bicêtre APHP, Le Kremlin-Bicêtre
Stanford University School of Medicine, Stanford
Sechenov Moscow First State Medical University, Moscow
"Atlas Medical Center", Moscow
Vladimirsky Moscow Regional Research Clinical Institute, Moscow
"Federal State Budgetary Institution V. A. Almazov Federal North-West Medical Research Centre of the Ministry of Health of the Russian Federation", Saint Petersburg
Interregional Clinical Diagnostic Center, Kazan'
"Centre Diabetes LLC", Samara
Novosibirsk State Regional Clinical Hospital, Novosibirsk
Antrium Multidisciplinary Medical Clinic, Barnaul
Regional State Budgetary Healthcare Institution Regional State Hospital, Krasnoyarsk
Massachusetts General Hospital, Boston
Rutgers - Robert Wood Johnson Medical School, New Brunswick
Universitätsklinik für Innere Medizin Klinische Abteilung für Endokrinologie und Diabetologie, Graz
Medizinische Universität Wien, Vienna
Magyar Honvedseg Egeszsegugyi Kozpont, Budapest
University of Pecs, Pécs
Szegedi Tudományegyetem, I. Belgyógyászati Klinika, Szeged
Policlinico di Monserrato U.O.C. Endocrinologia e Diabetologia, Monserrato
Fondazione Policlinico Universitario A. Gemelli Università Cattolica del S.Cuore S.C. Endocrinologia e Malattie del Metabolismo, Rome
Hospital of LUHS Kauno Klinikos, Kaunas
Vaidotas Urbanavicius Individuali Imonė, Vilnius
Katedra i Klinika Endokrynologii i Chorob Wewnetrznych Gdanski Uniwersytet Medyczny, Gdansk
Samodzielny Publiczny Szpital Kliniczny nr 1 we Wroclawiu, Klinika Endokrynologii, Diabetologii i Leczenia Izotopami, Wroclaw
"C.I. Parhon National Institute of Endocrinology I Clinical Endocrinology Department - Endemic goitier and its complications", Bucharest
Clinical Centre of Serbia, Clinic for Endocrinology Diabetes and Metabolic Diseases, Belgrade
Hospital Universitari Germans Trias i Pujol, Barcelona
University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham
Central Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Manchester
Royal Victoria Infirmary, Newcastle upon Tyne
Royal Hallamshire Hospital, Sheffield
Chiasma, Inc.
INDUSTRY